Clinical Trials on At Risk for HIV in New Zealand
Total 3358 results
-
Sebela Women's Health Inc.Synteract, Inc.Active, not recruitingWomen at Risk for PregnancyUnited States
-
Sebela Women's Health Inc.PRA Health SciencesNot yet recruitingContraception | Women at Risk for PregnancyUnited States
-
DePuy InternationalCompletedOsteoarthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Traumatic Femoral Fractures | Nonunion of Femoral FracturesNew Zealand
-
University of RochesterNational Institute of Mental Health (NIMH)Completed
-
Yale UniversityCompleted
-
Liggins InstituteRecruiting
-
Memorial Sloan Kettering Cancer CenterCompletedHigh Risk for Postoperative Cardiovascular EventsUnited States
-
ProtalixRecruiting
-
Tavotek BiotherapeuticsRecruiting
-
SurModics, Inc.Active, not recruitingHemodialysis Access FailureAustralia, New Zealand
-
Memorial Sloan Kettering Cancer CenterCompletedWomen at Increased Risk for Developing Breast CarcinomaUnited States
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHIV | Risk Reduction BehaviorUnited States
-
University of RochesterNational Heart, Lung, and Blood Institute (NHLBI); University of Texas; Clinical...Active, not recruiting
-
Arrowhead PharmaceuticalsRecruitingFacio-Scapulo-Humeral DystrophyNew Zealand
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Arcturus Therapeutics, Inc.Novotech CRORecruiting
-
Arthrosi TherapeuticsCompletedGout PatientsNew Zealand
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Arrowhead PharmaceuticalsCompleted
-
University of ConnecticutNational Institute on Drug Abuse (NIDA); Yale University; APT Foundation, Inc.CompletedRisk Behavior | HIV | Medication AdherenceUnited States
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Monash Medical CentreMonash University; University of Auckland, New Zealand; Hudson Institute of Medical... and other collaboratorsRecruiting
-
DePuy InternationalTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Traumatic Femoral Fractures | Nonunion of Femoral FracturesChina, Hong Kong, Italy, Korea, Republic of, New Zealand
-
Arrowhead PharmaceuticalsRecruitingMyotonic Dystrophy 1New Zealand, Australia
-
Hunter College of City University of New YorkCompletedHIV Infections | Sexual Risk | HIV Medication Adherence | Methamphetamine Use | Poly-substance UseUnited States
-
Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyCompleted
-
National Institute of Diabetes and Digestive and...National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaboratorsCompletedImpaired Glucose Tolerance | High Risk | Autoantibody Positive | Non-diabetic Relatives at Risk for Type 1 DiabetesUnited States, Canada, Germany
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)Completed
-
University Hospital, EssenFederal Ministry of Education and Reserach (BMBF)CompletedDetection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. | Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, | HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral...Germany
-
Ribon Therapeutics, Inc.RecruitingAtopic DermatitisAustralia, New Zealand
-
Bioventus LLCEnrolling by invitationMitigation of Fracture Non-union in Patients at RiskUnited States
-
New York State Psychiatric InstituteTerminatedClinical High Risk for PsychosisUnited States
-
University Hospital of CologneKarolinska Institutet; University Hospital of North Norway; Goethe University; McGill... and other collaboratorsUnknownPatients at High Risk of Antibacterial Treatment Upon AdmissionGermany
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)RecruitingClinical High Risk for Psychosis (CHR)United States
-
Fenway Community HealthBrown University; Emory University; Montefiore Medical Center; University of North...CompletedSexually Transmitted Diseases | HIV | Risk Reduction | Pre-exposure ProphylaxisUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingHigh Risk for Developing Breast CancerUnited States
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Northwell HealthTerminatedHigh Risk MC4R Genotype | Low Risk MC4R Genotype | One Week or Less Antipsychotic Lifetime ExposureUnited States
-
University of ConnecticutNational Institute on Drug Abuse (NIDA); APT Foundation, Inc.CompletedRisk Behavior | HIV/AIDS | Medication Adherence | Substance AbuseUnited States
-
PDS Biotechnology Corp.CompletedHigh-risk HPV Infection and Biopsy-proven CIN1United States
-
Smith & Nephew, Inc.RecruitingAvascular Necrosis | Non-inflammatory Degenerative Joint Disease, Including Osteoarthritis | Requires Correction of Functional Deformity | Requires Treatment of Fractures That Were Unmanageable Using Other TechniquesNew Zealand, Australia, Hong Kong
-
Yale UniversityTerminatedClinical High Risk for PsychosisUnited States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)CompletedFirst Episode Psychosis (FEP) | At Risk Mental State (ARMS)United States
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Enrolling by invitationFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsEnrolling by invitationNeurobehavioral Manifestations | Allergy | Microbial Colonization | Growth Disorders | Atopic Dermatitis | Obesity, Childhood | Metabolic Disturbance | Cognition | Lifestyle | Breastfeeding | Nutrition, Healthy | AtopySingapore, United Kingdom, New Zealand